Teratology pp 136-146 | Cite as

Screening Medicines for Teratogenicity: Problems of Interpretation

  • R. M. Atkinson

Abstract

It is some 12 years since screening for teratogenicity became an important part of the toxicity tests on new substances, especially medicines. Yet tests in use until now are not generally regarded as satisfactory, and the degree of protection they afford to mankind is unknown.

Keywords

Toxicity Teratogenicity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Becker, B. A.: The statistics of teratology. Teratology 9, 261–262 (1974).PubMedCrossRefGoogle Scholar
  2. Brent, R. L.: Drug testing for teratogenicity: its implications, limitations and application to man. pp. 31–43 in Klingberg, M. A., Abramovici, A. and Chemke, J. (Eds.): Drugs and Fetal Development. New York: Plenum Press 1972.Google Scholar
  3. Cahen, R L.: Evaluation of the teratogenicity of drugs. Clin. Pharmacol. Ther. 5, 480–514 (1964).PubMedGoogle Scholar
  4. Healy, M. J. R.: Animal litters as experimental units. Appl. Statist. 21, 155–159 (1972).CrossRefGoogle Scholar
  5. Kalter, H: Choice of the number of sampling units in teratology. Teratology 9, 257–258 (1974).PubMedCrossRefGoogle Scholar
  6. Li, C. C: Introduction to Experimental Statistics. Ch. 30: Multiple measurements (pp. 403 to 415). New York: McGraw-Hill 1964.Google Scholar
  7. Marriott, F. H. C: The Interpretation of Multiple Observations. New York: Academic Press 1974.Google Scholar
  8. Palmer, A. K.: Problems associated with the screening of drugs for possible teratogenic activity. Ch. 2 (pp. 16–33) in Woollam, D. H. M. and Morris, G. M. (Eds.): Experimental Embryology and Teratology 1. London: Elek Science (1974 a).Google Scholar
  9. Palmer, A. K.: Statistical analysis and choice of sample units. Teratology 10, 301–302 (1974 b).PubMedCrossRefGoogle Scholar
  10. Snedecor, G. W., Cochran, W. G.: Statistical Methods. 6th Ed., pp. 324–329. Ames, Iowa: Iowa State University Press 1967.Google Scholar
  11. Sokal, R. R., Rohlf, F. J.: Biometry. Ch. 13: Assumptions of the analysis of variance (pp. 367–402). San Francisco: Freeman 1969.Google Scholar
  12. Staples, R. E., Haseman, J. K.: Selection of appropriate experimental units in teratology. Teratology 9, 259–260 (1974).PubMedCrossRefGoogle Scholar
  13. Tuchmann-Duplessis, H.: Design and interpretation of teratogenic tests, pp.56–87 in Robson, J. M., Sullivan, F. M. and Smith, R. L. (Eds.): A Symposium on Embryopathie Activity of Drugs. London: Churchill 1965.Google Scholar
  14. Tuchmann-Duplessis, H.: Teratogenic drug screening. Present procedures and requirements. Teratology 5, 271–285 (1972).PubMedCrossRefGoogle Scholar
  15. Weil, C. S.: Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis or carcinogenesis. Fd. Cosmet. Toxicol. 8, 177–182 (1970).CrossRefGoogle Scholar
  16. Weil, C. S.: Choice of the number of sampling units in teratology. Teratology 10, 301 (1974).PubMedCrossRefGoogle Scholar
  17. W.H.O.: Principles for the testing of drugs for teratogenicity. Wld. Hlth Org. techn. Rep. Sen, 364 (1967).Google Scholar
  18. Wilson, J. G.: Environment and Birth Defects. Ch. 9: Collection and interpretation of results (pp. 173–193). New York: Academic Press 1973.Google Scholar
  19. Wilson, J. G.: Factors determining the teratogenicity of drugs, pp.205–217 in Elliott, H. W., Okun, R. and George, R. (Eds.): Ann. Rev. Pharmacol. 14. Palo Alto, Calif.: Annual Reviews Inc (1974).Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1975

Authors and Affiliations

  • R. M. Atkinson

There are no affiliations available

Personalised recommendations